Solid tumor
Conditions
Interventions
None listed
Sponsors
National Cancer Center Hospital East
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: 1)Written consent has been obtained. 2)18 years of age or older 3)have undergone or consented to undergo cancer genome profiling testing at a collaborating institution
Exclusion criteria
Exclusion criteria: 1)Judged by physician to be unsuitable for enrolment in the study.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Profile of genomic abnormalities in registered patients (percentage of evidence level A/B/R in the Guidance for Cancer Treatment based on gene panel tests using next-generation sequencers version 2.1) | — |
Secondary
| Measure | Time frame |
|---|---|
| Relationship between the profile of genomic abnormalities and clinical course, etc. | — |
Countries
Japan
Contacts
Public ContactYoichi Naito
National Cancer Center Hospital East Department of Medical Oncology
Outcome results
None listed